Sectors
IMNN
Imunon, Inc.
1.63
2 x 1.14
2 x 2.04
bid
ask
+
0.03
1.87%
2 @ 07:30 PM
1.63 +0.00 (0.00%)
| Ytd | -57.22% | |
| 1y | -72.51% |
1.55
day range
1.62
1.47
52 week range
6.04
| Open | 1.60 | Prev Close | 1.60 | Low | 1.55 | High | 1.62 | Mkt Cap | 9.15M |
| Vol | 18.40K | Avg Vol | 126.05K | EPS | -2.92 | P/E | N/A | Forward P/E | -0.73 |
| Beta | 2.13 | Short Ratio | 3.31 | Inst. Own | 7.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.72 | 200-d Avg | 2.80 | 1yr Est | 13.20 |
| Income Statement | |||
| Operating Expenses | 2.79M | ||
| Research and Development Expense | 1.46M | ||
| Selling, General and Administrative Expense | 1.33M | ||
| Operating Income | -2.79M | ||
| Interest Expense | 77.27K | ||
| Net Income | -2.81M | ||
| Net Income Common Stock | -2.83M | ||
| Net Income Common Stock (USD) | -2.83M | ||
| Consolidated Income | -2.81M | ||
| Earnings per Basic Share | -0.54 | ||
| Earnings per Basic Share (USD) | -0.54 | ||
| Earnings per Diluted Share | -0.54 | ||
| Earning Before Interest & Taxes (EBIT) | -2.74M | ||
| Earning Before Interest & Taxes (USD) | -2.74M | ||
| Preferred Dividends Income Statement Impact | 18.05K | ||
| Weighted Average Shares | 5.23M | ||
| Weighted Average Shares Diluted | 5.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.86M | ||
| Cash and Equivalents (USD) | 11.86M | ||
| Current Assets | 8.69M | ||
| Property, Plant & Equipment Net | 1.25M | ||
| Total Assets | 14.99M | ||
| Debt Current | 1.93M | ||
| Total Debt | 7.85M | ||
| Current Liabilities | 4.78M | ||
| Debt Non-Current | 5.91M | ||
| Total Liabilities | 10.80M | ||
| Accumulated Retained Earnings (Deficit) | -428.36M | ||
| Shareholders Equity | 4.19M | ||
| Shareholders Equity (USD) | 4.19M | ||
| Assets Non-Current | 6.30M | ||
| Total Debt (USD) | 7.85M | ||
| Liabilities Non-Current | 6.02M | ||
| Trade and Non-Trade Payables | 1.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 169.00K | ||
| Net Cash Flow from Financing | 10.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.07M | ||
| Capital Expenditure | -69.08K | ||
| Issuance (Purchase) of Equity Shares | 842.70K | ||
| Issuance (Repayment) of Debt Securities | 7.03M | ||
| Net Cash Flow from Investing | -69.08K | ||
| Net Cash Flow from Operations | -3.03M | ||
| Share Based Compensation | 548.63K | ||